Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.
Dylan Z Dieters-CastatorPeter F RambauLinda E KelemenGabrielle M SiegersGilles A LajoieLynne-Marie PostovitMartin KoebelPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
In summary, these findings support the use of multi-marker panels for the differential diagnosis of difficult cases resembling endometrioid carcinoma and HGSC.